| [1] |
Zhao Shuwen, Zhang Jingzhan, Kang Xiaojing.
Efficacy and safety of electron beam radiation therapy for Kaposi sarcoma and factors associated with treatment outcomes
[J]. Chinese Journal of Dermatology, 2026, 59(8): 759-766.
|
| [2] |
Wei Jin¹, Yan Huiwen¹, Zhang Jianzhong², Lun Wenhui¹.
Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis complicated by HIV infection: a clinical observation of 10 cases
[J]. Chinese Journal of Dermatology, 2026, 59(7): 671-674.
|
| [3] |
Liu Yifei, Kim Hyunok¹, Liu Pengyue³, Zhang Ximeng³, Wu Yan³.
Fractional CO? laser combined with topical botulinum toxin type A for the treatment of enlarged facial pores: a split-face self-controlled clinical trial
[J]. Chinese Journal of Dermatology, 2026, 59(7): 645-653.
|
| [4] |
Sun Songpeng, Long Junhong, Cao Bo, Xu Yue, Zhang Xiang′an, Cao Hui, Xie Jun, Gui Ping, Sun Xiaojun, Zhang Bo, Xu Zhijie, Li Jin′an, Wang Zhigang, Wu Wei, Yang Huiju, Wei Ping, Liu Congcong, Shen Qingbo, Yu Fan, Chu Hongchuan, Zhou Yangyang, Liu Jiaxin, Liu Yan, Huo Xingxiao, Chen Hang, Jing Tao, Gao Jing, Wang Yanxun, Wang Rui, Li Zhenyu, Zhang Shuxin.
Efficacy and safety of Fuzhiqing ointment versus triamcinolone acetonide and econazole nitrate cream in the treatment of chronic perianal eczema: a multicenter, randomized, double-blind, controlled, equivalence trial
[J]. Chinese Journal of Dermatology, 2026, 59(6): 564-570.
|
| [5] |
Li Ming, Li Yan, Li Linfeng.
Janus kinase inhibitors for the treatment of moderate-to-severe atopic dermatitis
[J]. Chinese Journal of Dermatology, 2026, 59(6): 582-585.
|
| [6] |
Wang Caixia, Xu Fan, Shi Jing, Zhu Hailian, Lu Guiling, Wang Hongmei.
Efficacy and safety of omalizumab and dupilumab for the treatment of bullous pemphigoid: a systematic review
[J]. Chinese Journal of Dermatology, 2026, 59(3): 262-268.
|
| [7] |
Xia Zhikuan, Ge Ge.
Laser therapy for vitiligo: clinical applications and prospects
[J]. Chinese Journal of Dermatology, 2026, 59(3): 213-217.
|
| [8] |
Wang Su, Wu Jintong, Li Wenyu, Zhang Cheng, Li Chengxin, Wang Rui.
Efficacy and safety of cold atmospheric plasma in the treatment of non-open Staphylococcus aureus skin infections in mice
[J]. Chinese Journal of Dermatology, 2026, 59(1): 44-50.
|
| [9] |
Yao Wo, Wang Huiying.
Lanadelumab in the treatment of hereditary angioedema: a systematic review of clinical trials
[J]. Chinese Journal of Dermatology, 2026, 59(1): 77-81.
|
| [10] |
Zhu Tingting, Li Weiran, Pan Zhaobing, Liu Hao, Tang Xianfa, Zhu Caihong, Huang Hequn, Duan Dawei, Zhang Ruochen, Chen Xiaojian, Wang Yang, Xue Qian, Zhang Jurui, Yang Lijing, Zhang Xuejun, Huang He, Zhang Bo, .
Efficacy of baricitinib combined with ruxolitinib cream in the treatment of six patients with progressive nonsegmental vitiligo: a clinical observation
[J]. Chinese Journal of Dermatology, 2025, 58(9): 856-859.
|
| [11] |
Guliziba·Tuersun, Zhao Yanan, Wang Hongjuan, Kang Xiaojing, Qu Yuanyuan.
Efficacy of autologous melanocyte transplantation combined with 308-nm light-emitting diode phototherapy at escalating doses in the treatment of refractory stable vitiligo: a clinical observation
[J]. Chinese Journal of Dermatology, 2025, 58(9): 852-856.
|
| [12] |
Wang Qin, Lin Jinran, Liu Qingmei, Wu Wenyu, .
Oral minoxidil in the treatment of alopecia areata
[J]. Chinese Journal of Dermatology, 2025, 58(7): 653-656.
|
| [13] |
Zhao Meiru, Xiao Meng, Zhang Xinmei, Zhang Junyan, Qi Yuqing, Wang Huiping.
Omalizumab for the treatment of eight patients with chronic spontaneous urticaria during pregnancy and lactation
[J]. Chinese Journal of Dermatology, 2025, 58(6): 536-539.
|
| [14] |
Li Hongyi, Wu Panpan, Wu Wenfeng, Peng Junsheng, Liu Qin, Lu Yingshan, Dong Jindian, Yang Zhibo.
Clinical efficacy and safety of Luofushan-Baicao oil in the treatment of Aedes albopictus bites: a paired, self-controlled study
[J]. Chinese Journal of Dermatology, 2025, 58(2): 178-181.
|
| [15] |
Huang He, Tang Xianfa, Li Weiran, Zhu Caihong, Li Yang, Liang Bo, Li Min, Wang Yang, Zhang Xuejun, Zhang Bo, .
Ruxolitinib phosphate 1.5% cream for the treatment of five cases of nonsegmental vitiligo
[J]. Chinese Journal of Dermatology, 2025, 58(12): 1169-1172.
|